Abstract
Background:
The residue at the site of activation of protein C is Arg in all species except the ray-finned fish, where it is Trp. This feature raises the question as to whether thrombin is the physiological activator of protein C across vertebrates.
Objective:
Establish if thrombin can cleave at Trp residues.
Methods:
The activity of thrombin wild-type and mutant D189S was tested with a library of chromogenic substrates and toward protein C wild-type and mutants carrying substitutions at the site of cleavage.
Results:
Thrombin has trypsin-like and chymotrypsin-like specificity and cleaves substrates at Arg or Trp residues. Cleavage at Arg is preferred, but cleavage at Trp is significant and comparable to that of chymotrypsin. The D189S mutant of thrombin has broad specificity and cleaves at basic and aromatic residues without significant preference. Thrombin also cleaves natural substrates at Arg or Trp residues, showing activity toward protein C across vertebrates, including the ray-finned fish. The rate of activation of protein C in the ray-finned fish is affected by the sequence preceding Trp at the scissile bond.
Conclusions:
The results provide a possible solution for the paradoxical presence of a Trp residue at the site of cleavage of protein C in ray-finned fish and support thrombin as the physiological activator of protein C in all vertebrates. The dual trypsin-like and chymotrypsin-like specificity of thrombin suggests that the spectrum of physiological substrates of this enzyme is broader than currently assumed.
Keywords: Blood coagulation, thrombin, protein C, serine proteases, chymotrypsin, trypsin
1. Introduction
Thrombin is a serine protease engaged in multiple functional roles in the blood [1]. As other proteases involved in blood coagulation, fibrinolysis and complement, thrombin features a trypsin-like specificity due to the presence of an Asp residue (D189) in the primary specificity pocket that confers preference for a basic residue (Arg or Lys) [2–4] at the P1 position of substrate [5]. In contrast, proteases featuring chymotrypsin-like specificity carry a Ser residue (S189) in the primary specificity pocket and cleave preferentially at aromatic residues (Phe or Trp) [2–4]. The two types of specificity, trypsin-like toward basic residues and chymotrypsin-like toward aromatic residues, have long been considered as mutually exclusive. In fact, trypsin cleaves basic residues 5–6 orders of magnitude faster than aromatic residues and the reverse is observed for chymotrypsin [6]. Pioneering studies have shown that the D189S replacement in trypsin is insufficient to achieve chymotrypsin-like specificity and additional replacements are needed in the 186- and 220- loops lining the primary specificity pocket and residue 172 [6, 7]. However, the same strategy fails to convert chymotrypsin to trypsin [8], suggesting that specificity is a distributed property arising from multiple domains of the structure. Whether such a conclusion extends to highly specialized enzymes like thrombin remains to be established.
In addition to its procoagulant and prothrombotic roles, i.e., cleavage of fibrinogen leading to clot formation and cleavage of protease activated receptor (PAR) 1 leading to platelet activation, thrombin functions as an anticoagulant by converting the zymogen protein C (PC) to its active form APC (Figure 1) with the assistance of the endothelial receptor thrombomodulin (TM) [1]. APC down-regulates the coagulation response by inactivating the cofactors V and VIII that are responsible for the amplification of thrombin generation from prothrombin [9]. APC also plays a cytoprotective role mediated by cleavage of PAR1 and PAR3 [10]. Blood coagulation evolved in the common vertebrate ancestor and the genes encoding prothrombin and PC have been identified in all classes of vertebrates [11, 12]. Thrombin activates PC in higher mammals [13], but it is unknown whether this is the case in other vertebrates. Specifically, it is unclear whether thrombin activates PC in ray-finned fish that carries a conserved Trp instead of Arg in the cleavage site (Figure 1), as observed in all other vertebrates [14]. Thrombin has a strong preference for synthetic and natural substrates carrying Arg at the P1 position [15], but can also cleave chromogenic substrates with Phe at P1 with significant specificity, unlike other trypsin-like proteases [16]. Furthermore, like chymotrypsin and unlike any other coagulation protease, thrombin is inhibited by heparin cofactor II that carries Leu at the P1 position [17]. Whether the broadened specificity of thrombin extends to natural substrates like PC in the ray-finned fish is investigated in this study to better understand its physiological importance.
Figure 1AB. Structural architecture of PC.

(A) Schematic representation of the multidomain assembly of PC comprised of a γ-carboxyglutamate (Gla), epidermal growth factor (EGF) 1 and 2, AP linker and serine protease domains. (B) Sequence of the AP linker in human and herring PC. The AP linker is numbered based on human mature PC as the sequence between the zymogen activation site at R169 and the perfectly conserved C141 that connects EGF2 to the protease domain. The APFISH variant was engineered by replacing in the AP the human sequence (underlined) with that of herring. The zymogen activation site is indicated by an arrow.
2. Methods
Mutations in the plasmids of interest were introduced using a Quick Change Lightning mutagenesis kit (Agilent Technologies). The APFISH plasmid was constructed by deleting the sequence 144PWKRMEKKRSHLKRDTEDQEDQVDPR169 in the activation peptide (AP) linker of human PC and replacing it with the sequence 137ILIHKSSFNTGPIQGLLPW155 from the AP linker of herring (Clupea harengus; XP_031415396.1) (Figure 1). PC variants were expressed in baby hamster kidney cells and purified as described[18]. Human thrombin wild-type (WT) or mutant D189S and rat anionic trypsin were expressed, purified and tested for activity as described [19, 20]. α-chymotrypsin (0.5–2 nM) from bovine pancreas (C4129) was from Sigma-Aldrich, while the chromogenic substrates H-D-Phe-Pro-Phe-p-nitroanilide (FPF), H-D-Phe-Pro-Arg-p-nitroanilide (FPR) and H-D-Phe-Pro-Trp-p-nitroanilide (FPW) were from MidWest Biotech (Fisher, IN). Measurements of the Michaelis-Menten parameters kcat and Km for cleavage of chromogenic substrates were carried out from direct integration of progress curves of substrate hydrolysis taking into account product inhibition [21]. The activation of PC by thrombin (0.5–200 nM) in complex with rabbit TM (100–400 nM; Prolytix) was monitored by a discontinuous assay under pseudo-first order conditions where the activation reaction was quenched at different time points with hirudin and activity was measured using the S-2366 (Diapharma) chromogenic substrate [22]. Experimental conditions for PC activation were: 20 mM Tris, 145 mM NaCl, 10 mM CaCl2, 0.1% PEG8000, 0.1% BSA, pH 7.5 at 37 °C. N-terminal sequencing was performed at the protein core facility of the Iowa State University. Intrinsic disorder was measured using the VSL2 algorithms [23] from the PONDR family of predictors.
3. Results
3.1. Cleavage of synthetic substrates with basic and aromatic residues at the P1 position
The specificity of thrombin was studied with a library of chromogenic substrates FPX, with residues FP at the P3-P2 positions fixed for optimal interaction with the enzyme and X at the P1 position carrying basic (Arg) or aromatic (Phe, Trp) residues. Thrombin shows highest specificity for FPR, as seen in previous studies [16, 24], but cleaves FPF with a kcat/Km comparable to that of chymotrypsin and FPW with a value about 50-fold lower (Table 1, Figure 2A). In contrast, trypsin cleaves FPF and FPW at rates 105-fold slower than chymotrypsin and 106-fold slower than FPR (Table 1, Figure 2A). These findings support the conclusion that thrombin is more versatile than trypsin in its P1 specificity and features a preference for basic residues at the P1 position that is not nearly absolute. An important corollary of this property is that the D189S substitution in thrombin reduces activity toward FPR but has no significant effect on the hydrolysis of FPF and FPW (Table 1, Figure 2A), thereby producing an enzyme with broad specificity toward basic and aromatic residues at the P1 position of substrate. This property is rare among proteases and only a few examples have been documented [25–27].
Table 1.
kcat/Km values (in μM−1s−1) for cleavage of chromogenic substrate by various serine proteases
| Trypsin | Chymotrypsin | WT Thrombin | D189S Thrombin | |
|---|---|---|---|---|
| FPR | 7.9±0.4 | 0.028±0.002 | 80±3 | 0.47±0.01 |
| FPF | 1.6±0.1 10−5 | 0.81±0.01 | 0.33±0.01 | 0.46±0.01 |
| FPW | 3.2±0.1 10−6 | 1.8±0.1 | 0.035±0.001 | 0.058±0.002 |
Experimental conditions: 20 mM Tris, 200 mM NaCl, 0.1% PEG8000, pH 8.0 at 25 °C
Figure 2AB. Protease specificity toward synthetic and natural substrates.

(A) Logarithm of the values of the specificity constant s=kcat/Km for the hydrolysis of the chromogenic substrates FPR, FPF and FPW (as indicated) by trypsin, chymotrypsin and thrombin, wild-type and mutant D189S (see also Table 1). (B) Logarithm of the values of the specificity constant s=kcat/Km for the hydrolysis of PC constructs (as indicated) carrying R169 (wild-type, 6A, APFISH-P1Arg) or W169 (R169W, 6A-R169W, APFISH) at P1 by thrombin wild-type and mutant D189S (see also Table 2).
3.2. Cleavage of physiological substrates with Trp at the P1 position
The ability of thrombin to cleave aromatic residues at the P1 position was tested with PC by replacing R169 at the site of cleavage with Trp, which is the residue found in all ray-finned fish (Figure 1). Earlier studies reported that thrombin would not activate the R169W mutant of Gla-domainless PC [28], but the assays were performed with low concentrations of thrombin and monitored over a short period of time (5–10 min). Longer incubation (5 hr) and higher thrombin concentration (80 nM) produce a detectable activation of the R169W mutant of PC (Figure 3) which is abolished by the thrombin specific inhibitor hirudin (Figure 3A), ruling out possible contamination by other proteases. Activation of the R169W of PC is also confirmed by SDS-PAGE analysis, where a progressive decrease in the concentration of single chain PC is accompanied by increased appearance of the heavy and light chains of APC (Figure 3B). N-terminal sequencing of the heavy chain reveals the sequence 170LIDGKM175 expected for cleavage at W169 and rules out potential contamination by bovine PC whose sequence is instead 179IVDGQE175. Finally, the R169W mutant of PC could be activated by chymotrypsin under conditions where no cleavage of wild-type PC would be observed (Figure 3C), ruling out the possibility of contamination of the R169W variant by forms carrying Arg at P1.
Figure 3ABC. Activation of the PC mutant R169W by thrombin.

(A) Activation by thrombin (80 nM) in the presence of TM (200 nM) measured after 0 hr (black) and 5 hr incubation, with (red) or without (blue) excess hirudin. APC activity was measured after quenching the reaction with hirudin and following cleavage of S-2366 at 405 nm. (B) SDS-PAGE analysis under reducing conditions following incubation with thrombin (IIa, 200 nM) and TM (400 nM). Activation is evident from the decrease of single chain (S.C.) PC and concomitant increase of heavy chain (H.C.) and light chain (L.C.) bands. (C) Progress curve of activation of PC wild-type (black) and mutant R169W (blue) by chymotrypsin (0.2 nM) monitored by following the hydrolysis of the APC specific substrate H-D-Asp-Arg-Arg-p-nitroanilide [45] at 405 nm. Experimental conditions are: 20 mM Tris, 145 mM NaCl, 10 mM CaCl2, 0.1% PEG8000, pH 7.5 at 37 °C.
Although thrombin in complex with TM can cleave the R169W mutant of PC, the rate of activation remains >1200-fold slower compared to wild-type PC (Table 2, Figure 2B). The observation is consistent with the results of chromogenic substrates (Table 1, Figure 2A) and confirms the preference of thrombin for basic residues at P1. On the other hand, the D189S mutant of thrombin activates the R169W mutant of PC at a rate nearly 20-fold faster than that of wild-type thrombin and 6-fold faster than that of wild-type PC (Table 2, Figure 2B), confirming its broad specificity (Table 1, Figure 2A).
Table 2.
kcat/Km values (in mM−1s−1) for PC activation by thrombin WT and mutant D189S in the presence of TM
| PC constructs with Arg at P1 | PC constructs with Trp at P1 | |||||
|---|---|---|---|---|---|---|
| WT | 6A | APFISH_P1-Arg | R169W | 6A R169W | APFISH | |
| WT | 220± 20 | 550±50 | 2000±300 | 0.18±0.04 | 0.7±0.1 | 7.8± 0.2 |
| D189S | 0.34±0.05 | 6.9±0.9 | 65±8 | 2.2±0.2 | 4±1 | 30±9 |
Experimental conditions: 20 mM Tris, 145 mM NaCl, 10 mM CaCl2, 0.1% PEG8000, 0.1% BSA, pH 7.5 at 37 °C
3.3. Role of the extended sequence preceding the scissile bond in PC
The activity of several serine proteases decreases orders of magnitude upon progressive truncation of the amino acids comprising the P4-P2 positions of substrate [29–32], because of removal of important interactions that position the scissile bond for optimal cleavage [24]. The extended sequence around the scissile site also affects the zymogen activation rate in several coagulation factors. Residues that occupy the P5-P11 position of the R271 cleavage site of prothrombin guide preferential attack by fXa at this site over the alternative R320 cleavage site [33]. Charge neutralization of the cluster of acidic residues in PC near the scissile bond significantly enhances the rate of activation by thrombin [22, 34–37], increases the propensity of promiscuous activation by non-physiological coagulation proteases [22] and autoactivation [34]. Similarly, shortening the length of the AP linker [38] or mutating disorder promoting residues [39] and glycosylation sites [39, 40] in this region modulates the activation rate of fX and its propensity for autoactivation.
Comparative sequence analysis has shown that the least conserved region of PC is the AP linker immediately upstream to the zymogen activation site [14]. During the emergence of placental mammals, the AP linker of PC evolved extensive structural modifications that included a novel pro-protein convertase processing site at the N-terminus, a significant elongation, an increase in the number of charged residues and sequence convergence of the important Pro at the P2 position that was lost during the emergence of tetrapods [14]. Hence, differences in the extended sequence near the scissile bond of PC from fish may promote cleavage by thrombin of Trp at P1. To test this hypothesis, we generated the APFISH chimera by replacing the entire AP linker of human PC with the analogous sequence from the Atlantic herring (Clupea harengus; XP_031415396.1) (Figure 1). The AP linker connects the EGF2 and protease domains and its C-terminus ends at the P1 residue (Figure 1). The APFISH chimera is activated by the thrombin-TM complex 43-fold faster than the R169W mutant of PC (Table 2, Figure 2B). Adding the W169R replacement in APFISH_P1-ARG increases the rate further to 10-fold higher than wild-type PC (Table 2, Figure 2B). On the other hand, the D189S mutant of thrombin activates APFISH and APFISH_P1-ARG at comparable rates (Table 2, Figure 2B), again consistent with its broad specificity.
The AP of ray-finned fish lacks acidic residues found in human PC (Figure 1) [22]. The contribution of this difference was tested with the 6A/R169W mutant of PC carrying Ala substitutions of all six acidic residues in the AP linker, along with the R169W replacement. The rate of activation of 6A/R169W by thrombin (Table 2) was not comparable to that observed with APFISH, supporting the conclusion that the AP sequence in ray-finned fish makes specific contributions not recapitulated by removal of potential electrostatic clashes, as observed for human PC. We have recently shown that the AP linker of mammals is the most disordered region of the sequence of PC [22]. Analysis of the sequence in herring PC reveals significant differences in the predicted disorder disposition scores, with the AP linker being highly ordered compared to the analogous region of human PC (Figures 4A,B). Interestingly, there is a negative correlation between the disorder disposition of the AP linker and the rate of activation by the thrombin-TM complex (Figure 4C,D), regardless of the nature of the P1 residue, basic or aromatic.
Figure 4ABCD. Disorder disposition of the AP linker of PC.

The disorder disposition affects the cleavage rate of the residue at P1 by the thrombin-TM complex. (A) Analysis of the primary sequences of human (blue), herring (purple), 6A (green), and APFISH (orange) using the VSL2 algorithm. (B) Average disorder disposition of the AP linker sequence. Correlation of the disorder disposition of the AP linker of PC and the kcat/Km values for activation of PC variants by the thrombin-TM complex carrying Arg (C) or Trp (D) at P1.
4. Discussion
Thrombin specificity has historically been defined as trypsin-like because of the presence of D189 in its primary specificity pocket [41] and a basic residue (Arg/Lys) at the P1 position of all known natural substrates [1]. A recent comparative sequence analysis has revealed that PC in all ray-finned fish carry Trp at P1, raising the question as to whether PC has activators other than thrombin and possibly other functions in ray-finned fish. The results presented here do not address these alternative possibilities but show that thrombin is more versatile than trypsin insofar as it is capable of cleaving synthetic and natural substrates with basic or aromatic residues at P1, even though it carries D189 in the primary specificity pocket of all species [14]. The trypsin-like specificity of thrombin predominates but it is not exclusive because of significant activity that is chymotrypsin-like. It is therefore possible that the dual trypsin-like and chymotrypsin-like specificity of thrombin allows the enzyme to function as the physiological activator of PC in mammals (carrying Arg at P1) and ray-finned fish (carrying Trp at P1). An intriguing possibility also arises for thrombin acting on other physiological targets, yet to be identified, by cleaving at aromatic residues. Interestingly, the GLLPW↓L sequence of the P5-P1’ residues around the scissile site (↓) cleaved by thrombin in herring PC is found in many human proteins (Supplementary Figure 1 and Table 3), including heparin binding EGF that plays an important role in hematopoiesis [42] and anoctamin-6 that regulates exposure of phosphatidylserine on membrane surfaces [43]. The GLLPW↓L sequence is also found in many bacterial proteins (Supplementary Figure 1 and Supplementary Table 1). Because clot formation is an integral part of host defense [44], we speculate that a thrombin with broad specificity would have been beneficial during the evolution of vertebrates if capable of proteolyzing and inactivating several prokaryotic proteins. Finally, an enzyme with broad specificity like the D189S mutant of thrombin may prove useful as a sequencing tool in proteomics.
Table 3.
Distribution of the GLLPW↓L sequence among human proteins
| Protein | Accession ID | P5-P1’ Sequence |
|---|---|---|
| Fuzzy Protein | NP_001339191.1 | XLLPWL |
| Autogenous vein graft remodeling associated protein | CAJ77183.1 | XLLPWL |
| S-adenosylmethionine synthetase | BAA08355.1 | GLLPWL |
| Heparin binding EGF | AAA50562.1 | XLXPWX |
| Immunoglobulin heavy chain junction region | MBB2077539.1 | GXXPWL |
| Anoctamin-6 | NP_001191732.1 | XLLPWX |
| hCG2045022 | EAW54630.1 | XXLPWL |
| Catenin-beta like | KAI2594789.1 | GLLXWL |
| Secretory carrier-associated membrane protein 5 isoform X1 | XP_047288174.1 | XXLXWL |
| Lipid storage droplet protein 5 | AAI31525.1 | XXLPWL |
| Glucosaminyl (N-acetyl) transferase family member 7 | KAI4006065.1 | XXLPWL |
| Taste receptor, type 2, member 39, isoform CRA_c | EAW51886.1 | GLXPWL |
| Zinc transporter ZIP13 isoform X1 | XP_054226442.1 | XXLPWL |
| 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | NP_612199.2 | XXLPWL |
| Bitter taste receptor T2R39 | BAD98035.1 | GLXPWL |
| Lysosomal amino acid transporter 1 | NP_001035214.1 | XXLPWL |
| Ig kappa light chain | CAA51128.1 | XLLPWL |
| Hemicentin 2 | KAI2554293.1 | XLLPWL |
| Protein furry homolog | XP_047285955.1 | XLLPWL |
| Stalled ribosome sensor GCN1 | NP_006827.1 | XLLPWL |
| GCN1 general control of amino-acid synthesis 1-like 1 | AAI53882.1 | XLLPWL |
| Retinal-specific phospholipid-transporting ATPase ABCA4 | 7E7I_A | GXLPWL |
| ATP-BINDING CASSETTE TRANSPORTER | AAC51144.1 | GXLPWL |
| Clathrin | EAW94395.1 | XLLPWL |
| GATOR complex protein DEPDC5 | 8FW5_A | LLPWLX |
X=variable amino acid residue.
Supplementary Material
Acknowledgments.
This study was supported in part by the National Institutes of Health Research Grants HL049413, HL139554 and HL147821.
Footnotes
Competing Interests. The Authors declare no competing financial interests.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Di Cera E Thrombin. Mol Aspects Med. 2008; 29: 203–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci. 1995; 4: 337–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hedstrom L Serine protease mechanism and specificity. Chem Rev. 2002; 102: 4501–24. [DOI] [PubMed] [Google Scholar]
- 4.Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci. 2008; 65: 1220–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 1967; 27: 157–62. [DOI] [PubMed] [Google Scholar]
- 6.Hedstrom L, Szilagyi L, Rutter WJ. Converting trypsin to chymotrypsin: the role of surface loops. Science. 1992; 255: 1249–53. [DOI] [PubMed] [Google Scholar]
- 7.Hedstrom L, Perona JJ, Rutter WJ. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant. Biochemistry. 1994; 33: 8757–63. [DOI] [PubMed] [Google Scholar]
- 8.Venekei I, Szilagyi L, Graf L, Rutter WJ. Attempts to convert chymotrypsin to trypsin. FEBS Lett. 1996; 383: 143–7. [PubMed] [Google Scholar]
- 9.Esmon CT. The protein C pathway. Chest. 2003; 124: 26S–32S. [DOI] [PubMed] [Google Scholar]
- 10.Griffin JH, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood. 2015; 125: 2898–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Davidson CJ, Tuddenham EG, McVey JH. 450 million years of hemostasis. J Thromb Haemost. 2003; 1: 1487–94. [DOI] [PubMed] [Google Scholar]
- 12.Doolittle RF. Step-by-step evolution of vertebrate blood coagulation. Cold Spring Harb Symp Quant Biol. 2009; 74: 35–40. [DOI] [PubMed] [Google Scholar]
- 13.Krem MM, Di Cera E. Molecular markers of serine protease evolution. Embo J. 2001; 20: 3036–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Stojanovski BM, Di Cera E. Comparative sequence analysis of vitamin K-dependent coagulation factors. J Thromb Haemost. 2022; 20: 2837–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Uliana F, Vizovisek M, Acquasaliente L, Ciuffa R, Fossati A, Frommelt F, Goetze S, Wollscheid B, Gstaiger M, De Filippis V, Auf dem Keller U, Aebersold R. Mapping specificity, cleavage entropy, allosteric changes and substrates of blood proteases in a high-throughput screen. Nat Commun. 2021; 12: 1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bush LA, Nelson RW, Di Cera E. Murine thrombin lacks Na+ activation but retains high catalytic activity. J Biol Chem. 2006; 281: 7183–8. [DOI] [PubMed] [Google Scholar]
- 17.Church FC, Noyes CM, Griffith MJ. Inhibition of chymotrypsin by heparin cofactor II. Proc Natl Acad Sci U S A. 1985; 82: 6431–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Stojanovski BM, Pelc LA, Zuo X, Di Cera E. Zymogen and activated protein C have similar structural architecture. J Biol Chem. 2020; 295: 15236–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bobofchak KM, Pineda AO, Mathews FS, Di Cera E. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J Biol Chem. 2005; 280: 25644–50. [DOI] [PubMed] [Google Scholar]
- 20.Prasad S, Cantwell AM, Bush LA, Shih P, Xu H, Di Cera E. Residue Asp-189 controls both substrate binding and the monovalent cation specificity of thrombin. J Biol Chem. 2004; 279: 10103–8. [DOI] [PubMed] [Google Scholar]
- 21.Krem MM, Di Cera E. Dissecting substrate recognition by thrombin using the inactive mutant S195A. Biophys Chem. 2003; 100: 315–23. [DOI] [PubMed] [Google Scholar]
- 22.Stojanovski BM, Pelc LA, Di Cera E. Role of the activation peptide in the mechanism of protein C activation. Sci Rep. 2020; 10: 11079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Peng K, Radivojac P, Vucetic S, Dunker AK, Obradovic Z. Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics. 2006; 7: 208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Vindigni A, Dang QD, Di Cera E. Site-specific dissection of substrate recognition by thrombin. Nat Biotechnol. 1997; 15: 891–5. [DOI] [PubMed] [Google Scholar]
- 25.Tsu CA, Perona JJ, Fletterick RJ, Craik CS. Structural basis for the broad substrate specificity of fiddler crab collagenolytic serine protease 1. Biochemistry. 1997; 36: 5393–401. [DOI] [PubMed] [Google Scholar]
- 26.Bone R, Fujishige A, Kettner CA, Agard DA. Structural basis for broad specificity in alpha-lytic protease mutants. Biochemistry. 1991; 30: 10388–98. [DOI] [PubMed] [Google Scholar]
- 27.Bauer CA, Brayer GD, Sielecki AR, James MN. Active site of alpha-lytic protease: enzyme-substrate interactions. Eur J Biochem. 1981; 120: 289–94. [DOI] [PubMed] [Google Scholar]
- 28.Yang L, Prasad S, Di Cera E, Rezaie AR. The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem. 2004; 279: 38519–24. [DOI] [PubMed] [Google Scholar]
- 29.Bauer CA. Active centers of Streptomyces griseus protease 1, Streptomyces griseus protease 3, and alpha-chymotrypsin: enzyme-substrate interactions. Biochemistry. 1978; 17: 375–80. [DOI] [PubMed] [Google Scholar]
- 30.Bauer CA, Thompson RC, Blout ER. The active centers of Streptomyces griseus protease 3 and alpha-chymotrypsin: enzyme-substrate interactions remote from the scissile bond. Biochemistry. 1976; 15: 1291–5. [DOI] [PubMed] [Google Scholar]
- 31.Stein RL, Strimpler AM, Hori H, Powers JC. Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements. Biochemistry. 1987; 26: 1301–5. [DOI] [PubMed] [Google Scholar]
- 32.Harris JL, Peterson EP, Hudig D, Thornberry NA, Craik CS. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem. 1998; 273: 27364–73. [DOI] [PubMed] [Google Scholar]
- 33.Stojanovski BM, Di Cera E. Role of sequence and position of the cleavage sites in prothrombin activation. J Biol Chem. 2021; 297: 100955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pozzi N, Barranco-Medina S, Chen Z, Di Cera E. Exposure of R169 controls protein C activation and autoactivation. Blood. 2012; 120: 664–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Richardson MA, Gerlitz B, Grinnell BW. Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant. Nature. 1992; 360: 261–4. [DOI] [PubMed] [Google Scholar]
- 36.Richardson MA, Gerlitz B, Grinnell BW. Charge reversal at the P3’ position in protein C optimally enhances thrombin affinity and activation rate. Protein Sci. 1994; 3: 711–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem. 1992; 267: 26104–9. [PubMed] [Google Scholar]
- 38.Rudolph AE, Mullane MP, Porche-Sorbet R, Daust HA, Miletich JP. The role of the factor X activation peptide: a deletion mutagenesis approach. Thromb Haemost. 2002; 88: 756–62. [PubMed] [Google Scholar]
- 39.Carnbring Bonde A, Rosenorn Hansen S, Johansson E, Rose Bjelke J, Lund J. Site-specific functional roles of the Factor X activation peptide in the intrinsic tenase-mediated Factor X activation. FEBS Lett. 2022; 596: 1567–75. [DOI] [PubMed] [Google Scholar]
- 40.Yang L, Manithody C, Rezaie AR. Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. J Thromb Haemost. 2009; 7: 1696–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bode W, Turk D, Karshikov A. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1992; 1: 426–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Vinante F, Rigo A. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis. Toxins (Basel). 2013; 5: 1180–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mattheij NJ, Braun A, van Kruchten R, Castoldi E, Pircher J, Baaten CC, Wulling M, Kuijpers MJ, Kohler R, Poole AW, Schreiber R, Vortkamp A, Collins PW, Nieswandt B, Kunzelmann K, Cosemans JM, Heemskerk JW. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage. FASEB J. 2016; 30: 727–37. [DOI] [PubMed] [Google Scholar]
- 44.Antoniak S The coagulation system in host defense. Res Pract Thromb Haemost. 2018; 2: 549–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dang QD, Di Cera E. Chromogenic substrates selective for activated protein C. Blood. 1997; 89: 2220–2. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
